ArticleOPEN ACCESS

Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia?

Expert Review of Hematology
DOI: 10.1080/17474086.2024.2354922
1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Author supplied keywords

Cite

CITATION STYLE

APA

Short, N. J., Kantarjian, H., & Jabbour, E. (2024). Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia? Expert Review of Hematology. Taylor and Francis Ltd. https://doi.org/10.1080/17474086.2024.2354922

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free